Menu
Peptide Database
Results
No peptides found
Featured

Use search to browse all 100+ peptides

LL-37

Cathelicidin, hCAP-18, FALL-39, CAP-18

Quick Stats
Studies 2230
Trials 95
Completed NA INTERVENTIONAL NCT01996423

Impact of Vitamin D Supplementation on Severity of Pediatric Atopic Dermatitis

View on ClinicalTrials.gov Updated Dec 15, 2025

Brief Summary

The purpose of this study is to determine whether oral vitamin D supplementation improves the clinical severity of atopic dermatitis in children. In addition, this study plans to evaluate the effects of vitamin D supplementation on several key aspects of the immune system of children with atopic dermatitis.

Interventions

Name: Vitamin D3
Type: DIETARY_SUPPLEMENT
Description:
Name: Placebo
Type: DIETARY_SUPPLEMENT
Description:

Primary Outcomes

Measure: Change in SCORAD index
TimeFrame: baseline and 6 weeks
Description: Change in Scoring Atopic Dermatitis (SCORAD) index after 6 weeks of vitamin D3 (VD3) supplementation or placebo in children with atopic dermatitis.

Trial Information

NCT ID

NCT01996423

Status

Completed

Study Type

INTERVENTIONAL

Phases

NA

Sponsor

Pontificia Universidad Catolica de Chile

Last Updated

December 15, 2025